Home Research-feed Channel Rankings GCT THU AI TR Open Data Must Reading

views: 28

Val Gebski

University of Sydney NHMRC Clinical Trials Centre, Sydney, NSW, Australia

Sign in to view more

Show Academic Trajectory

Ego Network

D-Core

Research Interests

Author Statistics

Experience

Education

Bio

None

Papers352 papers

Sort

By YearBy Citation

Testosterone treatment to prevent or revert type 2 diabetes in men enrolled in a lifestyle programme (T4DM): a randomised, double-blind, placebo-controlled, 2-year, phase 3b trial

Gary Wittert, Karen Bracken, Kristy P Robledo,Mathis Grossmann,Bu B Yeap,David J Handelsman,Bronwyn Stuckey,Ann Conway,Warrick Inder,Robert McLachlan,Carolyn Allan,David Jesudason

The lancet. Diabetes & endocrinology, no. 1 (2021): 32-45

WOSBibtex

Author response for "Uric Acid Predicts Long-Term Cardiovascular Risk in Type 2 Diabetes but Does Not Mediate the Benefits of Fenofibrate: the FIELD Study"

Jy Cao, B Waldman,R O’Connell,Sullivan, RS Scott, N Aryal,V Gebski,I Marschner,Taskinen,RJ Simes,N McGill, AJ Jenkins

Diabetes, Obesity and Metabolism, (2020)

Bibtex

The AGITG GAP Study: A Phase II Study of Perioperative Gemcitabine and Nab-Paclitaxel for Resectable Pancreas Cancer

Andrew P Barbour,Jaswinder S Samra,Koroush S Haghighi,Mark W Donoghoe,Matthew Burge, Marion T Harris,Yu Jo Chua, Jenna Mitchell, Nick O'Rourke, Howard Chan,Val J Gebski, Sivakumar Gananadha

Annals of Surgical Oncology, no. 7 (2020): 2506-2515

WOSBibtex

Patient-Specific Heart Constraint: A Tool for Optimization and Evaluation of Mean Heart Dose in Breast Cancer Patients

Rachel Ward, Katrina West, Drew Latty,Rachael Beldham-Collins, Dan Jia,Wei Wang, Shamira Cross,Val Gebski,Verity Ahern,Kirsty Stuart

Practical radiation oncology, (2020)

Bibtex

1430P Patient-reported outcome (PRO) results from AGITG DOCTOR: A randomised phase II trial of tailored neoadjuvant therapy for resectable oesophageal adenocarcinoma

R. Mercieca-Bebber,E.H. Barnes,K. Wilson, Z. Samoon,E.T. Walpole, T. Mai,S. Ackland,M. Burge, G. Dickie,D. Watson,J. Leung,T. Wang

Annals of Oncology, (2020)

Bibtex

Early vertebroplasty within 3 weeks of fracture for acute painful vertebral osteoporotic fractures: subgroup analysis of the VAPOUR trial and review of the literature

Terrence Diamond,William Clark,Paul Bird,Peter Gonski,Elizabeth Barnes,Val Gebski

European Spine Journal, no. 7 (2020): 1606-1613

WOSBibtex

Long-term quality of life outcomes of women treated for early-stage endometrial cancer

Saira Sanjida,Andreas Obermair,Val Gebski,Nigel Armfield,Monika Janda

International journal of gynecological cancer : official journal of the International Gynecological ..., (2020)

WOSBibtex

Preoperative cisplatin, fluorouracil, and docetaxel with or without radiotherapy after poor early response to cisplatin and fluorouracil for resectable oesophageal adenocarcinoma (AGITG DOCTOR): results from a multicentre, randomised controlled phase II trial

A P Barbour,E T Walpole, G T Mai,E H Barnes,D I Watson,S P Ackland,J M Martin,M Burge, R Finch,C S Karapetis,J Shannon,L M Nott

Annals of Oncology, no. 2 (2020): 236-245

WOSBibtex

First results for Australasian Gastrointestinal Trials Group (AGITG) control net study: Phase II study of 177Lu-octreotate peptide receptor radionuclide therapy (LuTate PRRT) +/- capecitabine, temozolomide (CAPTEM) for midgut neuroendocrine tumors (mNETs)

Nick Pavlakis, David Turner Ransom,David Wyld,Katrin Marie Sjoquist, Rebecca Asher,Val Gebski,Kate Wilson, Andrew Ddembe Kiberu,Matthew E. Burge, William Macdonald,Paul Roach,David A Pattison

Journal of Clinical Oncology, (2020): 604-604

Bibtex

Concordance between CA-125 and RECIST progression (PD) in patients with germline BRCA-mutated platinum-sensitive, relapsed ovarian cancer treated with a PARP inhibitor (PARPi) as maintenance therapy after response to chemotherapy

Angelina Tjokrowidjaja,Chee Khoon Lee,Michael Friedlander,Val Gebski,Laurence Gladieff,Jonathan A. Ledermann,Richard T. Penson,Amit M. Oza,Jacob Korach,Tomasz Huzarski,Luis Manso,Carmela Pisano

Journal of Clinical Oncology, (2020): 6014-6014

Bibtex

Vertebroplasty has an important role in managing patients with severe pain when performed early and with appropriate technique

William Clark,Paul Bird,Terry Diamond,Peter Gonski,Val Gebski

Internal Medicine Journal, no. 5 (2020): 647-648

Bibtex

The incidence of peritoneal carcinomatosis and impact on outcomes in relapsed early T4 colorectal cancer

Rosemary Habib,Val Gebski, Kenneth Micklethwaite,Duncan McLeod, James Toh, Toufic El-Khoury, Nimalan Pathma-Nathan,Grahame Ctercteko,Kavitha Gowrishankar,Nicholas Wilcken,Mark Wong,Adnan Nagrial

Journal of Clinical Oncology, (2020): 73-73

Bibtex

Patient Specific Heart Constraint: A tool for optimisation and evaluation of mean heart dose in breast cancer patients

Rachel Ward, Katrina West, Drew Latty,Rachael Beldham-Collins, Dan Jia,Wei Wang, Shamira Cross,Val Gebski,Verity Ahern,Kirsty Stuart

Practical radiation oncology, (2020)

WOSBibtex

Analysis of angiogenic and stromal biomarkers in a large malignant mesothelioma cohort

Puey Ling Chia,Prudence Russell, Khashi Asadi,Bibhusal Thapa,Val Gebski,Carmel Murone,Marzena Walkiewicz,Ulf Eriksson,Andrew M Scott,Thomas John

Lung cancer (Amsterdam, Netherlands), (2020): 1-8

WOSBibtex

Effect of antibiotics on urine leakage in women with refractory detrusor overactivity: A phase IIb randomized trial

Zhuoran Chen,Kate H Moore,Kylie J Mansfield, Samantha Ognenovska,Wendy Allen,Katrina Parkin,Chinmoy Mukerjee, Nanda R Aryal,Val Gebski

Neurourology and urodynamics, (2020)

WOSBibtex

Concordance between CA-125 and RECIST progression in patients with germline BRCA-mutated platinum-sensitive relapsed ovarian cancer treated in the SOLO2 trial with olaparib as maintenance therapy after response to chemotherapy

Angelina Tjokrowidjaja,Chee K Lee,Michael Friedlander,Val Gebski,Laurence Gladieff,Jonathan Ledermann,Richard Penson,Amit Oza,Jacob Korach,Tomasz Huzarski,Luis Manso,Carmela Pisano

European journal of cancer (Oxford, England : 1990), (2020): 59-67

WOSBibtex

Is mucinous histology a prognostic marker in early and advanced colorectal cancer

Rosemary Habib,Val Gebski, Kenneth Micklethwaite,Duncan McLeod, James Toh, Nimalan Pathma-Nathan, Toufic El-Khoury,Grahame Ctercteko,Kavitha Gowrishankar,Nicholas Wilcken,Mark Wong,Adnan Nagrial

Journal of Clinical Oncology, (2020): 253-253

Bibtex

Uric Acid Predicts Long-Term Cardiovascular Risk in Type 2 Diabetes but Does Not Mediate the Benefits of Fenofibrate: the FIELD Study

J Y Cao, B Waldman, R O'Connell, Sullivan,R S Scott, N Aryal,V Gebski, I Marschner,Taskinen,R J Simes,N McGill,A J Jenkins

Diabetes, obesity & metabolism, (2020)

WOSBibtex

Quality of life in patients with cervical cancer after open versus minimally invasive radical hysterectomy (LACC): a secondary outcome of a multicentre, randomised, open-label, phase 3, non-inferiority trial

Michael Frumovitz,Andreas Obermair,Robert L Coleman,Rene Pareja, Aldo Lopez, Reitan Ribero, David Isla, Gabriel Rendon, Marcus Q Bernadini,Alessandro Buda, Renato Moretti-Marquez, Albert Zevallos

LANCET ONCOLOGY, no. 6 (2020): 851-860

WOSBibtex

Radiation-induced oesophagitis in breast cancer: Factors influencing onset and severity for patients receiving supraclavicular nodal irradiation

Katrina West,Michal Schneider,Caroline Wright,Rachael Beldham-Collins, Natalie Coburn,Ken Tiver,Val Gebski,Kirsty E Stuart

Journal of medical imaging and radiation oncology, (2019)

WOSBibtex

View All

Base Info Papers Patents Projects